Zobrazeno 1 - 9
of 9
pro vyhledávání: '"O. I. Boev"'
Autor:
M. V. Baturina, G. I. Mamtseva, O. I. Boev, V. B. Yarovitsky, E. V. Grudina, V. A. Baturin, O. V. Borodina, V. P. Telbuh, S. N. Rudenko, M. V. Baturin
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 0, Iss 4, Pp 33-35 (2018)
The blood plasma IgG autoantibodies to human protein S-100, to NMDA-receptors and to dopamine receptor type 2 were determined in 13 epilepsy patients with secondary generalized seizures, 16 - in Parkinson patients, 33 - in schizophrenia patients at t
Externí odkaz:
https://doaj.org/article/0e2d1a323e6e4d649cdb6ce4754a6e11
Autor:
O. I. Boev, O. G. Bychkova
Publikováno v:
Public Health. 2:35-46
Reducing suicide-related mortality rate is one of the tasks outlined within the Russian national demographic policy. The purpose of this work is to create a regional model for monitoring intentional self-harm with non-lethal outcome (attempted suicid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a87cf59bfee4ebc01f47789a7210a50
https://doi.org/10.21045/2782-1676-2021-2-1-35-46
https://doi.org/10.21045/2782-1676-2021-2-1-35-46
Autor:
O. I. Boev, I. V. Boev
Publikováno v:
ПСИХОФИЗИОЛОГИЯ И ПСИХОНЕЙРОЭНДОКРИНОЛОГИЯ.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f5c6c712b1046ae96a55a4ab086d93d
https://doi.org/10.38006/9612-62-6.2022.88.90
https://doi.org/10.38006/9612-62-6.2022.88.90
Autor:
A. A. Rogozhina, A. O. Averkova, E. A. Zubova, L. O. Minushkina, V. A. Brazhnik, O. N. Ivanova, M. A. Chichkova, N. R. Khasanov, E. D. Kosmacheva, O. I. Boeva, D. A. Zateyshchikov
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 10 (2023)
Aim. To assess the possibility of familial hypercholesterolemia (FH) detection among patients with early coronary artery disease (CAD) in practice in comparison with data from different populations. Patients with early manifestations of CAD are a pro
Externí odkaz:
https://doaj.org/article/f41139a48f6a4da18bfe7de9ad6a3c87
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 9, Pp 86-91 (2019)
The review provides current data on the pathogenesis of calcific aortic valve disease (CAVD) — a widespread disease with unfavorable prognosis. Currently, there are no effective therapeutic methods for the prevention and treatment of this pathology
Externí odkaz:
https://doaj.org/article/76355541930f44eb84838472eb552e17
Autor:
V. A. Brazhnik, L. O. Minushkina, R. R. Guliev, A. O. Averkova, A. A. Rogozhina, O. S. Koroleva, E. A. Zubova, E. A. Karmanchikova, N. R. Khasanov, M. A. Chichkova, O. I. Boeva, A. S. Galyavich, D. A. Zateyshchikov
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 3, Pp 7-16 (2019)
Aim. To identify the risk factors for bleeding of BARC scale 2-5 types in patients after acute coronary syndrome (ACS).Material and methods. The data of 1502 patients from the open multicenter study, ORACUL II, were used — 894 men (59,5%) and 608 w
Externí odkaz:
https://doaj.org/article/a85235e782c04ed4bcf0e75d27748916
Autor:
E. V. Shcheglova, A. I. Laipanova, M. K. Baikulova, Z. K. Chotchaeva, S. Sh. Rogova, V. N. Kolesnikov, O. I. Boeva
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 10, Pp 107-112 (2017)
Aim. Apolipoprotein E (apoE) and paraoxonase 1 (PON1) participate in regulation of blood lipoprotein levels, as well as in their hydrolysis and oxidation. We assumed that individual alleles of the apoE and PON1 genes, along with the changes in concen
Externí odkaz:
https://doaj.org/article/80a3d40c4f2f428b9961fae56c417862
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 12, Pp 126-128 (2015)
THE CASE OF SUCCESSFUL APPLICATION OF EMBOLIZING SYSTEM IN DISTAL PERFORATION OF CORONARY ARTERY.
Externí odkaz:
https://doaj.org/article/ff3dd7d40cb64efea348e810cdc0f476
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 6, Iss 4, Pp 25-29 (2007)
Aim. To study the complex somato-typological and psycho-typological features of coronary heart disease (CHD) patients, to assess prognostic value of these features, to evaluate the potential of genetic markers in persons with high CHD risk. Material
Externí odkaz:
https://doaj.org/article/759dc2fe238b4d2992e50f6167e166a7